karbala journal of pharmaceutical sciences

Background: Most studies showed that the incidence of asthma is frequently associated with increased body mass index (BMI), vitamin D deficiency has been proposed as a risk factor that could explain a significant proportion of increased pattern of asthma prevalence. This study was aimed to track a correlation between body mass index and vitamin D status effect on asthma control in asthmatic patients.
Patients and Methods: This is a prospective randomized -controlled open-label interventional study to evaluate effect of vitamin D3 on asthma control and it's correlation with body mass index in asthmatic patients who are allocated into two main groups: Group 1: Include 20 patients who have diagnosed with asthma are assigned to receive conventional therapy for asthma according to disease stage and severity for three months period. Group 2: Include 24 patients who have diagnosed with asthma are assigned to receive conventional therapy for asthma according to disease stage and severity plus 2000 I.U vitamin D3 fast dissolve mini tablet (Natrol, USA) for three months period. Serum 25-OH vitamin D level, Body mass index (BMI), asthma control test (ACT) scoring system was measured both initially and after three months treatment.
Results: A highly significant improvement in asthma control found in patients after 3 months treatment with vitamin D3 supplement compared to pre treatment level (P<0.01), and was found significantly that among the 10 (42%) obese patients in group 2 with vitamin D deficiency, 6(25%) patients gained vitamin D insufficiency and 2(8%) patients gained vitamin D sufficiency after supplementation with vitamin D3 (P<0.01). After treatment body mass index inversely correlated with vitamin D level in patients receive conventional therapy, meanwhile in patients with vitamin D3 supplement the change in the body mass index after vitamin D3 treatment was parallel to the improvement in endogenous vitamin D level. Also the reduction in the body mass index after vitamin D3 treatment produce a positive correlation with asthma control test, though no significant (P>0.05). No direct correlation was found between endogenous vitamin D level and asthma control test in both study groups.
Conclusion: After vitamin D3 supplement in the current study, the change in the body mass index produce improvement in endogenous vitamin D status parallel to the change in the body mass index and markedly improvement in asthma control. Also the reduction in the body mass index after vitamin D3 treatment was positively correlated with asthma control.

Bronchial asthma is a major public health concern affecting 100-150 million people worldwide. Elevated total serum immunoglobulin E (IgE) is considered as an objective marker of allergy and has been associated with a number of respiratory disorder.Interleukin-12(IL-12) is a key cytokine involved in regulating the balance between TH1and TH2 cells by promoting TH1 response .Reduced capacity to produce this cytokine could lead aberrant TH2 development .The objective in this to find if any correlation between serum IgE level and serum interleukin-12 with severity of bronchial asthma for both the definitive diagnosis and the therapeutic strategy. A total of fifty patients with age 12years and below ( 28 males and 22 females) and twenty five of case controls with matched age and sex were randomly selected from apparently healthy individuals from January to June of 2010 who were attending the outpatient department in Kerbala teaching pediatrics hospital with symptoms suggestive of bronchial asthma .The patients who were not on any anti asthma medication in previous one week were included in the study. Blood sample was taken from each patient at time of attending , sera were separated and kept frozen at -200C until used .Serum interleukin -12 and total IgE levels were done by solid phase enzyme –linked immunosorbent assay (ELISA). A significant decrease of serum levels of IL-12 was found in bronchial asthmatic children compared with normal controls .This significant decrease of IL-12was observed in sever asthmatic patients compared with mild and moderate cases. However there is increase of mean serum total IgE in bronchial asthmatic children compared to healthy control groups .mean serum IgE levels were increased as the severity of asthma increased . The present study suggested that the increased serum total levels IgE in bronchial asthmatic patients beside decreasing the serum interleukin-12 could be considered as a key component in bronchial asthma pathogenesis and hence their therapeutic manipulation may be help in bronchial asthma management.

Background: Asthma is a chronic inflammatory disease of the airways because body exposure to foreign materials that stimulate immune response characterized by secretion of cytokines from inflammatory cells.
Objective: Diagnosis of asthma to detect about IgE,IL 1B,IL 2IL 8,,IL10 ,and IL12 in patients clinically suspected .
Patients and Methods:50 blood samples out patients were collected in a labeled 5 ml tubes,aged (26 years to 58 years ) were tested by Enzyme Linkined Immuno Sorbant Assay to detect IgE,IL 1B,IL 2IL 8,,IL10 ,and IL12 were carried in Al-Hussein Hospital in Kerbala ,during the period from May to Augest 2010.
Results:50 patients were evaluated for asthma and correlation between IL 1B,IL 2,IL 8,IL 10 ,IL 12 values (20,76,62,44,76)% respectively and IgE value (50)%.Increasing values of IL2,IL 8,IL 10,IL 12 (36,26,24,32)%respectively at ages(37-47)years were led to decreased IgE value(10%),and IL 2,IL 8 values were (24,22)% respectively comparion with IgE(10%).
Conclusions: Importance studying factors( IL 1B,IL 2,IL 8,IL 10 ,IL 12) in diagnosis of Asthmatic patients after clinically diagnosis .